MingMed

We are an innovative biopharmaceutical company dedicated to the discovery, development and commercialization of novel drugs for global unmet medical needs. Guided by our mission – “To explore the cause of disease and deliver better medicines for humanity (知因，明醫，為人), we leverage our integrated R&D and operational excellence to built and advance a synergistic portfolio. Our core focus spans ophthalmic drugs, recombinant botulinum toxin, immuno-oncology drugs and companion animal medicines, all developed in-house. With strong translation capability - from early discovery to commercialization - we are committed to delivering first-in-class treatments that make a meaningful difference in patients' lives.